145
Special Interest Group sessions (virtual)
informal, discussion-based meeting for members and nonmembers of the Association for Research in Vision and Ophthalmology, Inc. (ARVO)
Special Interest Group sessions (virtual)
informal, discussion-based meeting for members and nonmembers of the Association for Research in Vision and Ophthalmology, Inc. (ARVO)
Datum
10.06.2025, 09:00 - 10:30
Sprache
Englisch
Gebühren ab
gebührenfrei
Veranstalter
Association for Research in Vision and Ophthalmology, Inc. (ARVO)
Organisator
Association for Research in Vision and Ophthalmology, Inc. (ARVO)
1801 Rockville Pike, Suite 400
US - MD 20852-5622 Rockville
Tel.: +1 240 221 2900
Fax: +1 240 221 0370
The ARVO Special Interest Group (SIG) sessions are informal, discussion-based meetings designed to bring together groups with a common interest to discuss research challenges, issues, and opportunities. They are not scientific sessions and should not focus on presenting new research.
-
Basisinformation
Datum10.06.2025, 09:00 - 10:30SpracheEnglischGebühren abgebührenfreiVeranstalterAssociation for Research in Vision and Ophthalmology, Inc. (ARVO)
OrganisatorAssociation for Research in Vision and Ophthalmology, Inc. (ARVO)
1801 Rockville Pike, Suite 400
US - MD 20852-5622 Rockville
Tel.: +1 240 221 2900
Fax: +1 240 221 0370 -
Programm
2025 SIG Sessions Schedule
(all times are EDT)
June 10
9 - 10:30am- Endpoints and trial design in inherited retinal diseases
- Harmonizing and designing novel endpoints in degenerative retinal diseases to foster innovation
Noon - 1:30pm
- Controversies in Dry Eye Disease (DED): Myth busting with DREAM data
- Axon regeneration: What is required to reach the bedside?
6 - 7:30pm
- Standardizing structural and functional endpoints for inherited retinal disorders in clinical trials
9 - 10:30pm
- Setting up a lab as a new PI: Challenges and perspectives.
June 12
9 - 10:30am
- Full-field Stimulus Threshold (FST) testing as a potential endpoint for regulatory consideration in clinical trials for inherited retinal diseases
- Charles Bonnet Syndrome: New hallucinations
Noon - 1:30pm
- Vitreoschisis, vitreous cortex remnants and hyalocytes: Novel insights into their role in PVR management
9 - 10:30pm
- NF1 optic nerve glioma: A novel model for vision restoration research
- Advances in MGD diagnostics, treatment and management: Perspectives from clinical science, basic science and artificial intelligence
2025 SIG Session Details
(all times are EDT)
Endpoints and trial design in inherited retinal diseases
June 10 | 9 - 10:30am
Organizers
Rachel Huckfeldt, MD, PhD
Massachusetts Eye and EarJacque Duncan, MD, FARVO
University of California, San Francisco - Gebühren
- Buchung / Anmeldung
- Zertifizierung
-
Sponsoren